MedDataX Logo

A Study to Compare the Pharmacokinetics Profile of DWCZP Tablet 100mg and Clozaril® Tablet 100mg

NCT01654601 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2017-03-27

Study results available
· View outcomes & findings →

Summary

To evaluate the pharmacokinetics of oral multiple-dose of DWCZP tablet 100mg.

Conditions

  • Schizophrenia

Interventions

DRUG

DWCZP

Multiple dose

DRUG

Clozaril

multiple-dose

Sponsors & Collaborators

  • The Catholic University of Korea

    collaborator OTHER

  • Konkuk University Hospital

    collaborator OTHER

  • Naju National Hospital

    collaborator OTHER

  • Seoul National Hospital

    collaborator OTHER_GOV

  • Wonkwang University

    collaborator OTHER

  • DongGuk University

    collaborator OTHER

  • Dong Wha Pharmaceutical Co. Ltd.

    lead INDUSTRY

Principal Investigators

  • Won-Myoung Bahk, M.D. · The Catholic University of Korea, Yeouido St.Mary's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2013-04-30
Completion
2013-08-31

Countries

  • South Korea

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01654601 on ClinicalTrials.gov